[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.173.184. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,167
Citations 0
Comment & Response
April 5, 2016

Clinical Breast Examination and Breast Cancer Screening Guideline

Author Affiliations
  • 1University of Washington, Seattle
  • 2University of Texas MD Anderson Cancer Center, Houston
  • 3National Comprehensive Cancer Network, Fort Washington, Pennsylvania
JAMA. 2016;315(13):1403-1404. doi:10.1001/jama.2016.0686

To the Editor In their updated guideline, the American Cancer Society (ACS) “does not recommend clinical breast examination [CBE] for breast cancer screening among average-risk women at any age.”1 The ACS overstepped the boundaries of evidence with this recommendation because the effect of this change has never been studied. Furthermore, the ACS should have emphasized that their new recommendation to withhold CBE screening assumes that women are otherwise undergoing recommended mammographic screening. Approximately one-third of women who should be screened lack access to these services.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×